<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04796311</url>
  </required_header>
  <id_info>
    <org_study_id>LH.INV.F2019002</org_study_id>
    <nct_id>NCT04796311</nct_id>
  </id_info>
  <brief_title>Imunomodulation in Acute Pancreatitis</brief_title>
  <official_title>Imunomodulation in Acute Pancreatitis- How Can Cytokines, B and T Cells Predict the Outcome of the Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Filipa Malheiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital da Luz, Portugal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute pancreatitis is an acute inflammatory pathology of the pancreas with activation of both&#xD;
      innate and adaptive immune system, including T and B lymphocytes and release of inflammatory&#xD;
      cytokines. We aim to characterize the circulating profile of T and B cells, its regulatory&#xD;
      populations and B cell maturation, as well as inflammatory cytokines, in a prospective way of&#xD;
      50 patients with acute pancreatitis admitted to Hospital da Luz Lisboa. Blood samples will be&#xD;
      collected at hospital admission, 48h, one month and 6 months after hospitalization of&#xD;
      patients, relating these values to the severity of acute pancreatitis. Patients with acute&#xD;
      pancreatitis in the previous 6 months, diabetes mellitus, pregnant women, uncontrolled&#xD;
      comorbidity and terminal neoplasms will be excluded. A control group of 30 ambulatory&#xD;
      individuals observed at the Hospital da Luz Lisboa will be recruited. Laboratory evaluation&#xD;
      will be performed at the Immunology Laboratory of NOVA Medical School.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">February 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To characterize the immune profile of patients with acute pancreatitis at admission, 48h after admission and at 1 month and 6 months after discharge.</measure>
    <time_frame>6 months</time_frame>
    <description>Blood collection for evaluation of B and T cell subpopulations as well as IL-1, IL6, TNFalpha will be performed in patients with acute pancreatitis in the first 24h of diagnosis, at 48 hours of hospitalization, one month after hospitalization and six months after the first determination.&#xD;
Application of the BISAP (Bedside Index of Severity in Acute Pancreatitis)score at admission&#xD;
Blood collection for RCP (mg/dl) determination in peripheral blood of these patients at hospital admission, 48h after the first determination and at discharge from hospital</description>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Acute Pancreatitis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>T cells, B cells and cytokines testing</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        hospitalized patients with acute pancreatitis from 18 to 85 years old&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hospitalized patients with acute pancreatitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute pancreatitis in the last 6 months diabetes mellitus, pregnant women,&#xD;
             uncontrolled comorbidity such as organ disease (cardiac, renal, hepatic) and terminal&#xD;
             neoplasms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Filipa Malheiro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital da Luz, Lisboa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Filipa Malheiro, MD</last_name>
    <phone>00351916237467</phone>
    <email>afmalheiro@hospitaldaluz.pt</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helena Martins</last_name>
    <email>helena.costa.martins@luzsaude.pt</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital da Luz</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filipa Malheiro, MD</last_name>
      <phone>00351916237467</phone>
      <email>afmalheiro@hospitaldaluz.pt</email>
    </contact>
    <contact_backup>
      <last_name>Helena Martins</last_name>
      <email>helena.costa.martins@luzsaude.pt</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital da Luz, Portugal</investigator_affiliation>
    <investigator_full_name>Filipa Malheiro</investigator_full_name>
    <investigator_title>Medical doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

